GeneTex Augments Its GPCR Reagent Portfolio With a Highly Specific CXCR2 Recombinant Monoclonal Antibody
GeneTex, a multinational antibody manufacturer, announces a new addition to its growing product line of validated recombinant monoclonal antibodies against G protein-coupled receptors (GPCRs). CXC...